Study group (n = 58) | Modified controls (n = 116) | p value | 95% CI | |
---|---|---|---|---|
IV continuous drugs mg/kg/h | ||||
Propofol 0–24 h prior to extubation, Mean±SD [median; IQR; min–max] | 1.5 ± 1 [1.5; 0.6–1.9; 0.3–3.3] | 2.1 ± 1 [1.9; 1.4–2.3; 0.4–6.2] | 0.034 | 1.72, 2.4 |
Propofol 24–48 h prior to extubation, Mean±SD [median; IQR; min–max] | 1.4± 0.6 [1.32; 0.8–1.9; 0.4–2.4] | 2.1 ± 1.1 [2.1; 1.2–2.5; 0.4–4.9] | 0.009 | 1.7, 2.6 |
Midazolam 0–24 h prior to extubation, Mean ±SD [median; IQR; min–max] | None given | 0.12 ± 0.1 [0.09; 0.04–0.2; 0.03–0.33] | 0.889 | 0.04-0.21 |
Midazolam 24–48 h prior to extubation, Mean±SD [median; IQR; min–max] | None given | 0.08 ± 0.07 [0.05; 0.03 − 0.1; 0.02–0.2] | 0.571 | 0.005, 0.15 |
Morphine 24–48 h prior to extubation, Mean±SD [median; IQR; min–max] | None given | None given | ||
Fentanyl 0–24 h prior to extubation, Mean ±SD [median; IQR; min–max] | 0.02 ± 0.04 [0.001; 0.0007–0.05; 0–0.1] | 0.02 ± 0.28 [0.002; 0.0008–0.003; 0–1.05] | 0.672 | -0.05, 0.26 |
Fentanyl 24–48 h prior to extubation, Mean ±SD [median; IQR; min–max] | 0.06 ± 0.1 [0.002; 0.001–0.003; 0–0.2] | 0.003 ± 0.001 [0.003; 0.001− 0.003; 0–0.1] | 1 | 0.002, 0.004 |
Remifentanil 0–24 h prior to extubation, Mean±SD [median; IQR; min–max] | 0.01± 0.02 [0.006; 0.003 − 0.009; 0–0.08] | 0.01 ± 0.01 [0.008; 0.004–0.01; 0–0.06] | 0.331 | 0.005, 0.015 |
Remifentanil 24–48 h prior to extubation, Mean ±SD [median; IQR; min–max] | 0.006 ± 0.003 [0.007;0.005 − 0.001; 0–0.01] | 0.008 ± 0.003 [0.007; 0.005–0.01; 0–0.01] | 0.516 | 0.006,0.009 |
Dexmedetomidine 24–48 h prior to extubation, Mean ±SD [median; IQR; min–max] | None given | 0.4 ± 0.13 [0.4; 0.2–0.4; 0.3–0.5] | 0.5 | − 0.95, 1.64 |
Dexmedetomidine 0–24 h prior to extubation, Mean±SD [median; IQR; min–max] | 0.6 ± 0.3 [0.6; 0.35–0.9; 0.3–1] | 0.6 ± 0.1 [0.6; 0.5–0.7; 0.5–0.7] | 1 | 0.49, 0.69 |
Drugs given by bolus, mg | ||||
Methadone 0–24 h prior to extubation, Mean±SD [median; IQR; min–max] | 44 ± 36.5 [30; 15–80; 10–100] | 48.3 ± 43.4 [30; 12.5–50; 5–120] | 0.898 | 14.93, 81.72 |
Methadone 24–48 h prior to extubation, Mean ±SD [median; IQR; min–max] | 48 ± 35.8 [60; 10–80; 10–85] | 70 ± 36.5 [60; 32.5–67.5; 30–120] | 0.530 | 36.22, 103.77 |
Clonex 0–24 h prior to extubation, Mean ±SD [median; IQR; min–max] | 0.91 ± 0.63 [1; 0.25–1; 0.25–1.5] | 1.9 ± 1.7 [1; 0.75–1.9; 0.5–6] | 0.209 | 0.66, 3.27 |
Clonex 24–48 h prior to extubation, Mean ±SD [median; IQR; min–max] | None given | 2.9 ± 1.7 [2.5; 1.5–4; 1.5–6] | 0.286 | 1.11, 4.71 |
Quetiapine 0–24 h prior to extubation, Mean ±SD [median; IQR; min–max] | 187.5 ± 176.2 [112.5; 81.25–368.75; 75–450] | 72.7 ± 36.1 [75 ; 37.5–93.8; 25–150] | 0.106 | 48.44, 97.01 |
Quetiapine 24–48 h prior to extubation, Mean ±SD [median; IQR; min–max] | 133.8 ± 86.9 [112.5; 63.75–225; 60–250] | 58.9 ± 47.2 [50; 15.6–75; 12.5–150] | 0.190 | 15.3, 102.55 |
Clozapine 0–24 h prior to extubation, Mean ±SD [median; IQR; min–max] | 500 ± 141.4 [500; 400–600; 400–600] | None given | ||
Clozapine 24–48 h prior to extubation, Mean±SD [median; IQR; min–max] | 500± 141.4 [500; 400–600; 400–600] | None given | ||
Halidol 0–24 h prior to extubation, Mean ±SD [median; IQR; min–max] | 3.5 ± 2.1 [3.5, 2–3.5; 2–5] | 20 ± 21.7 [10; 5–37.5; 5–60] | 0.143 | − 2.75, 42.75 |